Federal Register Notice: FDA has determined that Pfizer’s Zithromax (azithromycin) 250-mg oral capsules were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve ANDAs for azithromycin 250-mg oral capsules. To view this notice, click here.
